Back
Shattuck Labs Vs. Kymera Therapeutics Industry Stock Comparison
Sell
40
STTK
Shattuck Labs
Last Price:
3.63
Seasonality Move:
-23.39%
Buy
60
KYMR
Kymera Therapeutics
Last Price:
46.42
Seasonality Move:
25.63%
Sell
40
Shattuck Labs (STTK)
is a Sell
Is Shattuck Labs a Buy, Sell or Hold?
- The current Shattuck Labs [STTK] share price is $3.75. The Score for STTK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- STTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $47.30. The Score for KYMR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STTK Stock Price Chart
What is Shattuck Labs's stock price today?
-
The Shattuck Labs share price today is $3.75
The current trend is relatively stagnant and STTK is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $47.30
The current trend is moderately bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
STTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 53.2 | Buy |
| Chaikin Money Flow: | 38217 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.33 - 3.69) | Buy |
| Bollinger Bands (100): | (2.99 - 8.01) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 55.12 | Buy |
| Chaikin Money Flow: | -310819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.47 - 48.27) | Buy |
| Bollinger Bands (100): | (33.14 - 45.2) | Buy |
STTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.71 | Buy |
| 20-day SMA: | 3.57 | Buy |
| 50-day SMA: | 3.74 | Buy |
| 200-day SMA: | 6.87 | Sell |
| 8-day EMA: | 3.7 | Buy |
| 20-day EMA: | 3.63 | Buy |
| 50-day EMA: | 4 | Sell |
| 200-day EMA: | 5.45 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.23 | Buy |
| 20-day SMA: | 47.07 | Buy |
| 50-day SMA: | 44.55 | Buy |
| 200-day SMA: | 36.24 | Buy |
| 8-day EMA: | 46.68 | Buy |
| 20-day EMA: | 46.2 | Buy |
| 50-day EMA: | 43.82 | Buy |
| 200-day EMA: | 36.62 | Buy |
Shattuck Labs Earnings Growth & STTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.04 per share, an increase this year of $0.50 per share, and an increase next year of $0.05 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
Shattuck Labs Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||